You just read:

Can-Fite Receives $500,000 Payment as Part of $3 Million Distribution Deal for Liver Cancer Drug Namodenoson (CF102) in South Korea

News provided by

Can-Fite BioPharma Ltd.

21 Dec, 2016, 07:00 ET